A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Management of metastatic esophagogastric junction adenocarcinoma
2018
Journal of Cancer Metastasis and Treatment
Preserved Fulltext
How to cite this article: Toihata T, Imamura Y, Watanabe M, Baba H. Management of metastatic esophagogastric junction adenocarcinoma. J Cancer Metastasis Treat 2018;4:24. http://dx. Abstract The prognosis of metastatic disease of esophagogastric junction adenocarcinoma remains poor, despite using a variety of regimens using cytotoxic agents. Recent understanding of molecular characteristic and tumor microenvironment of this cancer is currently instigating new therapeutic options. In this
doi:10.20517/2394-4722.2017.82
fatcat:p2zqjetl7jcojmdicrq7chzlle